Seroprevalence against SARS-CoV-2 after booster vaccination in a prison in Alicante (Spain)

Frontiers in Public Health, Год журнала: 2025, Номер 13

Опубликована: Янв. 28, 2025

Background Confinement conditions in prison communities are associated with increased susceptibility to infectious outbreaks. The COVID-19 pandemic has been characterized by high transmissibility and clinical severity resulting a number of infections deaths worldwide. Vaccination crucial tool mitigating its devastating effects. aim this study is asses the prevalence antibodies against Spike protein SARS-CoV-2 vaccinated prisoners staff at specific Alicante. Methods A cross-sectional epidemiological was designed for population scope using rapid lateral flow immunochromatography serological test, conducted on July 27, 2023. Demographic variables were collected through questionnaire. Statistical analysis performed SPSS 29.0 software. Results total 560 people participated study; predominant profile men (77.3%) an average age 45.7 years. 71.4% subjects 28.6% staff. Regarding detection anti-SARS-CoV-2 obtained 60.9% sample gave positive result. 69.1% participants received last dose 2022 or later 62.2% booster doses. vaccines administered Biontech/Pfizer Moderna 88.6% cases. 59.5% had suffered from 67.0% did not have any comorbidity. In regression analysis, it observed that stronger statistical relationship presence were: years since vaccine (aOR: 0.08; 95%CI: 0.05; 0.16) doses 4.8; 2.9; 8.0) presenting comorbidity 4.3; 2.4; 8.0). more better response seropositivity, 72.5% result while reached 56.3%. Conclusion vaccination status within community following initiation primary immunization subsequent doses, shows low coverage (60.9%), which below expectations given strategies implemented start pandemic. There notable differences rates between prisoners. These disparities concerning, authorities responsible public health should take proactive approach ensuring among

Язык: Английский

Unveiling Disease X: Strategies for Tackling the New Frontier of Infectious Diseases

Zoonoses, Год журнала: 2024, Номер 4(1)

Опубликована: Янв. 1, 2024

Disease X stands as a symbol for subset of emerging infectious diseases rising to prominence significant challenge global health security. This comprehensive review delves into the historical context, precise definition, and illustrative case studies disease X, including notable examples, such COVID-19, SARS, Ebola. The discussion then transitions an examination potential origins with particular focus on zoonotic pathways influence environmental factors. concludes suite proposed strategies aimed at prevention containment emphasizing critical role vigilant surveillance, swift response mechanisms, necessity fostering international cooperation.

Язык: Английский

Vaccines and vaccination in prison settings: availability and model of service delivery in 20 European countries

BMC Public Health, Год журнала: 2024, Номер 24(1)

Опубликована: Окт. 5, 2024

Язык: Английский